Authors:
Malecki, J
Wiersma, S
Bresnitz, E
DiFerdinando, G
Lurie, P
Nalluswami, K
Hathcock, L
Siegel, L
Adams, S
Walks, I
Davies-Coles, J
Richardson, M
Brechner, R
Stroube, R
Burans, J
Citation: J. Malecki et al., Investigation of bioterrorism-related anthrax, 2001 (Reprinted from MMWR, vol 50, pg 1008-1010, 2001), J AM MED A, 286(21), 2001, pp. 2662-2663
Authors:
Malecki, J
Wiersma, S
Labinson, R
Kamal, L
Bresnitz, E
Diferdinando, G
Lurie, P
Nalluswami, K
Hathcock, L
Siegel, L
Adams, S
Walks, I
Davies-Coles, J
Richardson, M
Brechner, R
Stroube, R
Citation: J. Malecki et al., Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis (Reprinted from MMWR, vol 50, pg 973-76, 2001), J AM MED A, 286(20), 2001, pp. 2536-2537
Authors:
Malecki, J
Wiersma, S
Cahill, T
Grossman, M
Hochman, H
Tapper, M
Pomeranz, M
Friedman-Kien, A
Gurtman, A
Bresnitz, E
DiFerdinando, G
Lurie, P
Nalluswami, K
Frank, D
Siegel, L
Adams, S
Walks, I
Davies-Coles, J
Chiriboga, C
Brechner, R
Peterson, E
Bresoff-Matcha, S
Galbraith, M
Eisold, J
Martin, G
Citation: J. Malecki et al., Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax (Reprinted from MMWR, vol 50, pg 941-948, 2001), J AM MED A, 286(19), 2001, pp. 2392-2396
Authors:
Malecki, J
Wiersma, S
Cahill, K
Grossman, M
Hochman, H
Gurtman, A
Bresnitz, E
DiFerdinando, G
Lurie, P
Nalluswami, K
Siegel, L
Adams, S
Walks, I
Davies-Coles, J
Brechner, R
Peterson, E
Frank, D
Bresoff-Matcha, S
Chiriboga, C
Eisold, J
Martin, G
Citation: J. Malecki et al., Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001 (Reprinted from MMWR, vol 50, pg 909-919, 2001), J AM MED A, 286(18), 2001, pp. 2226-2232
Authors:
Bush, L
Malecki, J
Wiersma, S
Cahill, K
Fried, R
Grossman, M
Borkowsky, W
Citation: L. Bush et al., Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001 (Reprinted from MMWR, vol 50, pg 889, 2001), J AM MED A, 286(17), 2001, pp. 2086-2088
Authors:
Dobbins, JG
Belay, ED
Malecki, J
Buck, BE
Bell, M
Cobb, J
Schonberger, LB
Citation: Jg. Dobbins et al., Creutzfeldt-Jakob disease in a recipient of a dura mater graft processed in the US: Cause or coincidence?, NEUROEPIDEM, 19(2), 2000, pp. 62-66
Authors:
Dziegielewski, JO
Machura, B
Malecki, J
Bartczak, TJ
Czurak, W
Citation: Jo. Dziegielewski et al., The synthesis, spectroscopic characterization, crystal and molecular structure of [ReBr3(NO)(dppe)](0.60)[ReBr4(dppe)](0.40), POL J CHEM, 74(2), 2000, pp. 191-198
Citation: J. Malecki et al., Kinetic studies of cAMP-induced allosteric changes in cyclic AMP receptor protein from Escherichia coli, J BIOL CHEM, 275(12), 2000, pp. 8480-8486
Citation: J. Malecki et M. Dutkiewicz, Nonlinear dielectric effect study of tetrahydrofuran association in benzene and cyclohexane solutions, J SOL CHEM, 28(2), 1999, pp. 101-116
Authors:
Izumi, T
Malecki, J
Chaudhry, MA
Weinfeld, M
Hill, JH
Lee, JC
Mitra, S
Citation: T. Izumi et al., Intragenic suppression of an active site mutation in the human apurinic/apyrimidinic endonuclease, J MOL BIOL, 287(1), 1999, pp. 47-57
Citation: J. Malecki et Z. Wasylewski, The sequential mechanism of guanidine hydrochloride-induced denaturation of cAMP receptor protein from Escherichia coli. A fluorescent study using 8-anilino-1-naphthalenesulfonic acid, J PROTEIN C, 17(8), 1998, pp. 745-755